RESEARCHER PROFILE

Derya Tilki

← Back to Universität Hamburg

D

Universität Hamburg

Prostate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchBreast Cancer Treatment StudiesBladder and Urothelial Cancer TreatmentsUrinary Bladder and Prostate Research

Derya Tilki works in Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Breast Cancer Treatment Studies, Bladder and Urothelial Cancer Treatments, Urinary Bladder and Prostate Research. Recorded institutional associations include Koç University, Universität Hamburg, University Medical Center Hamburg-Eppendorf.

1,010Publications
24,227Citations
70H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

    2020 · 2,802 citations
  2. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent

    2024 · 1,246 citations
  3. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer

    2020 · 1,079 citations
  4. The Lancet Commission on prostate cancer: planning for the surge in cases

    2024 · 738 citations
  5. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review

    2018 · 523 citations
  6. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer

    2024 · 352 citations
  7. Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations

    2019 · 247 citations
  8. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)

    2019 · 243 citations
  9. Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort

    2011 · 212 citations
  10. Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model

    2014 · 212 citations
  11. Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort

    2009 · 201 citations
  12. Soft Tissue Surgical Margin Status is a Powerful Predictor of Outcomes After Radical Cystectomy: A Multicenter Study of More Than 4,400 Patients

    2010 · 194 citations
  13. Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer

    2011 · 186 citations
  14. Biomarkers in prostate cancer – Current clinical utility and future perspectives

    2017 · 167 citations
  15. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    2023 · 166 citations
  16. Nerve-sparing Surgery Technique, Not the Preservation of the Neurovascular Bundles, Leads to Improved Long-term Continence Rates After Radical Prostatectomy

    2015 · 164 citations
  17. External Validation of the European Association of Urology Biochemical Recurrence Risk Groups to Predict Metastasis and Mortality After Radical Prostatectomy in a European Cohort

    2019 · 158 citations
  18. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review

    2020 · 149 citations
  19. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy

    2010 · 144 citations
  20. Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review

    2018 · 143 citations
  21. Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron‐sparing surgery in patients with renal cell carcinoma

    2009 · 142 citations
  22. Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

    2024 · 135 citations
  23. Association Between the Number of Dissected Lymph Nodes During Pelvic Lymphadenectomy and Cancer-Specific Survival in Patients with Lymph Node–Negative Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy

    2011 · 134 citations
  24. Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021

    2022 · 130 citations
  25. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes

    2019 · 126 citations

← Return to the university profile